Fore Biotherapeutics

Lately:2 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Leading the future of targeted therapies for the hardest to treat cancers. Wednesday, October 15, 202512:00 pm ET.

Employees
51-200estimated range
Website
fore.bio

These are the key facts about Fore Biotherapeutics on Alion as of Nov 17, 2026. It has raised $105.4M in 2 funding rounds. The latest round is Series D of $67.4M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Financials

Funding rounds, investors and revenue on record.

$105.4MTotal raised
Series DLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2026$67.4M1 record
2025$38M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Sources: the outlets named on each headline, each story once